HealthTree Logo
search more_vert
close
person Sign In / Create Account
Venetoclax For Multiple Myeloma
Posted: May 24, 2023
Venetoclax For Multiple Myeloma image

HealthTree University: Therapies On The Horizon - Venetoclax

Learn about Venetoclax, a promising drug for the treatment of B cell malignancies, including lymphomas and multiple myeloma. This drug specifically targets the anti-apoptotic protein BCL-2. Watch the video below for more information on its administration and success rates in clinical trials, including in combination with other drugs like dexamethasone and bortezomib. Don't miss out on this exciting new development in cancer treatment! HealthTree University.

Venetoclax

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Ariel Grajales-Cruz, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube